Japan Artificial Intelligence In Cancer Diagnostics Market Size & Outlook
- Healthcare IT
- AI in Healthcare
- Artificial Intelligence In Cancer Diagnostics Market Outlook
- AI in Healthcare
Global Market
Related Markets
Ask Prism AI about the artificial intelligence in cancer diagnostics market
Get cited answers from GVR research on market growth, segments, regulations and forecasts.
- Source-linked answers
- Market-specific context
- Traceable figures
Japan artificial intelligence in cancer diagnostics market highlights
- The Japan artificial intelligence in cancer diagnostics market generated a revenue of USD 15.6 million in 2025 and is expected to reach USD 94.5 million by 2033.
- The Japan market is expected to grow at a CAGR of 23.9% from 2026 to 2033.
- In terms of segment, software was the largest revenue generating component in 2025.
- Services is the most lucrative component segment registering the fastest growth during the forecast period.
Artificial intelligence in cancer diagnostics market data book summary
| Market revenue in 2025 | USD 15.6 million |
| Market revenue in 2033 | USD 94.5 million |
| Growth rate | 23.9% (CAGR from 2026 to 2033) |
| Largest segment | Software |
| Fastest growing segment | Services |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Software, Hardware, Services |
| Key market players worldwide | Microsoft Corp, Roche Holding AG, Quest Diagnostics Inc, Medial EarlySign, CancerCenter.AI, Therapixel, Tempus, Kheiron, SkinVision |
Other key industry trends
- In terms of revenue, Japan accounted for 4.6% of the global artificial intelligence in cancer diagnostics market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China artificial intelligence in cancer diagnostics market is projected to lead the regional market in terms of revenue in 2033.
- South Korea is the fastest growing regional market in Asia Pacific and is projected to reach USD 35.7 million by 2033.
Japan is embracing AI in many forms and the government is expected to invest around USD 100 billion in the coming 5 years to construct hospitals that are backed by AI. According to Healthcare Asia, the Japanese government is expected to establish 10 AI-based hospitals in the coming years, which will help address concerns such as a shortage of medical personnel and rising medical expenses.
Thus, the government is making significant investments in AI technologies, as it is considered an essential driver of future competitiveness. Growing awareness about advanced technologies is expected to boost usage of AI in diagnostics.
For instance, in July 2018, two Japanese research institutes succeeded in incorporating AI solutions for diagnosing early-stage stomach cancer at a high precision rate of 95% for healthy tissues and 80% for cancer tissues. According to National Cancer Centre and Riken, AI solutions take 0.004 seconds to analyze whether an obtained endoscopic image contains normal stomach tissue or early-stage cancer tissue.
No credit card required*
Publish Date: Jun 22, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Artificial Intelligence In Cancer Diagnostics Market Scope
Artificial Intelligence In Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Microsoft Corp | View profile | 221,000 | One Microsoft Way, Redmond, WA, United States, 98052-6399 | www.microsoft.com |
| Roche Holding AG | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Quest Diagnostics Inc | View profile | 48,000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | www.questdiagnostics.com |
| Medial EarlySign | View profile | 11-50 | Hod Hasharon, HaMerkaz, Israel, Asia | earlysign.com/ |
| CancerCenter.AI | View profile | 11-50 | Wroclaw, Dolnoslaskie, Poland, Europe | cancercenter.ai |
| Therapixel | View profile | 11-50 | Nice, Provence-Alpes-Cote d'Azur, France, Europe | www.therapixel.com/ |
| Tempus | View profile | 501-1000 | Chicago, Illinois, United States, North America | www.tempus.com |
| Kheiron | View profile | 11-50 | London, England, United Kingdom, Europe | www.kheironmed.com/ |
| SkinVision | View profile | 11-50 | Amsterdam, Noord-Holland, The Netherlands, Europe | skinvision.com |
Japan Artificial Intelligence In Cancer Diagnostics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Artificial Intelligence In Cancer Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Software was the largest segment with a revenue share of 66.67% in 2025.
Horizon Databook has segmented the Japan artificial intelligence in cancer diagnostics market based on software, hardware, services covering the revenue growth of each sub-segment from 2021 to 2033.
Japan is embracing AI in many forms and the government is expected to invest around USD 100 billion in the coming 5 years to construct hospitals that are backed by AI. According to Healthcare Asia, the Japanese government is expected to establish 10 AI-based hospitals in the coming years, which will help address concerns such as a shortage of medical personnel and rising medical expenses.
Thus, the government is making significant investments in AI technologies, as it is considered an essential driver of future competitiveness. Growing awareness about advanced technologies is expected to boost usage of AI in diagnostics.
For instance, in July 2018, two Japanese research institutes succeeded in incorporating AI solutions for diagnosing early-stage stomach cancer at a high precision rate of 95% for healthy tissues and 80% for cancer tissues. According to National Cancer Centre and Riken, AI solutions take 0.004 seconds to analyze whether an obtained endoscopic image contains normal stomach tissue or early-stage cancer tissue.
- Japan Artificial Intelligence In Cancer Diagnostics Market Component Outlook (Revenue, USD Million , 2021-2033)
- Software
- Hardware
- Services
- Japan Artificial Intelligence In Cancer Diagnostics Market Cancer Type Outlook (Revenue, USD Million , 2021-2033)
- Colorectal Cancer
- Lung Cancer
- Prostate Cancer
- Others
- Breast Cancer
- Brain Tumor
- Japan Artificial Intelligence In Cancer Diagnostics Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospital
- Surgical Centers and Medical Institutes
- Others
Reasons to subscribe to Artificial Intelligence In Cancer Diagnostics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Artificial Intelligence In Cancer Diagnostics Market Outlook databook
- Our clientele includes a mix of Artificial Intelligence In Cancer Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan Artificial Intelligence In Cancer Diagnostics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Japan Artificial Intelligence In Cancer Diagnostics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Japan Artificial Intelligence In Cancer Diagnostics Market, 2021-2033 (US$M)
Japan artificial intelligence in cancer diagnostics market statistics, by component, 2021-2033 (US$M)
